COP
54
-2
EW
39
2
PBI
65
5
GRMN
64
2
ORLY
60
7
EXR
60
3
PGR
63
3
FTI
76
3
MRO
40
-15
FDX
40
4
NAVI
47
3
PDCO
38
3
DGX
50
2
MTB
65
2
VRSN
57
4
GLW
46
4
TMO
47
3
AMGN
38
-6
ROK
47
-8
CMCSA
52
4
COP
54
-2
EW
39
2
PBI
65
5
GRMN
64
2
ORLY
60
7
EXR
60
3
PGR
63
3
FTI
76
3
MRO
40
-15
FDX
40
4
NAVI
47
3
PDCO
38
3
DGX
50
2
MTB
65
2
VRSN
57
4
GLW
46
4
TMO
47
3
AMGN
38
-6
ROK
47
-8
CMCSA
52
4
Financhill
Back

RxSight Vs. Perspective Therapeutics Industry Stock Comparison

Sell
6

RXST
RxSight

Last Price:
45.47
Seasonality Move:
35.19%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.20
Seasonality Move:
34.33%
Sell
6
RxSight (RXST) is a Sell

Is RxSight a Buy, Sell or Hold?

  • The current RxSight [RXST] share price is $45.05. The Score for RXST is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • RXST is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXST Stock Price Chart

What is RxSight's stock price today?

  • The RxSight share price today is $45.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

RXST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.59 Sell
Relative Strength Index (14 RSI): 37.97 Sell
Chaikin Money Flow: -74921 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.69 - 51.67) Sell
Bollinger Bands (100): (46.48 - 54.08) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

RXST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.87 Buy
20-day SMA: 48.38 Sell
50-day SMA: 49.68 Sell
200-day SMA: 52.77 Sell
8-day EMA: 45.55 Sell
20-day EMA: 47.31 Sell
50-day EMA: 49.16 Sell
200-day EMA: 48.82 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

RxSight Earnings Growth & RXST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.29 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

RxSight Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):